Pavonine Balance Sheet Health
Financial Health criteria checks 4/6
Pavonine has a total shareholder equity of ₩74.3B and total debt of ₩38.2B, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are ₩131.2B and ₩56.9B respectively. Pavonine's EBIT is ₩1.4B making its interest coverage ratio 0.4. It has cash and short-term investments of ₩7.7B.
Key information
51.4%
Debt to equity ratio
₩38.16b
Debt
| Interest coverage ratio | 0.4x |
| Cash | ₩7.68b |
| Equity | ₩74.25b |
| Total liabilities | ₩56.95b |
| Total assets | ₩131.20b |
Recent financial health updates
We Think Pavonine (KOSDAQ:177830) Can Stay On Top Of Its Debt
Apr 05
Pavonine (KOSDAQ:177830) Has A Somewhat Strained Balance Sheet
Dec 22
Recent updates
We Think Pavonine (KOSDAQ:177830) Can Stay On Top Of Its Debt
Apr 05If You Had Bought Pavonine (KOSDAQ:177830) Shares Five Years Ago You'd Have Earned 77% Returns
Mar 02Will the Promising Trends At Pavonine (KOSDAQ:177830) Continue?
Jan 26Pavonine (KOSDAQ:177830) Has A Somewhat Strained Balance Sheet
Dec 22Financial Position Analysis
Short Term Liabilities: A177830's short term assets (₩49.4B) exceed its short term liabilities (₩49.1B).
Long Term Liabilities: A177830's short term assets (₩49.4B) exceed its long term liabilities (₩7.9B).
Debt to Equity History and Analysis
Debt Level: A177830's net debt to equity ratio (41%) is considered high.
Reducing Debt: A177830's debt to equity ratio has reduced from 96.4% to 51.4% over the past 5 years.
Debt Coverage: A177830's debt is well covered by operating cash flow (49.2%).
Interest Coverage: A177830's interest payments on its debt are not well covered by EBIT (0.4x coverage).